As of 2026-10-02, the EV/EBITDA ratio of Intra-Cellular Therapies Inc (ITCI) is -118.23. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ITCI's latest enterprise value is 13,739.84 mil USD. ITCI's TTM EBITDA according to its financial statements is -116.21 mil USD. Dividing these 2 quantities gives us the above ITCI EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.7x - 15.9x | 11.4x |
| Forward P/E multiples | 11.7x - 15.5x | 14.0x |
| Fair Price | (9.86) - (14.07) | (10.95) |
| Upside | -107.5% - -110.7% | -108.3% |
| Date | EV/EBITDA |